Clinical significance of the tumor markers CYFRA 21-1 and neuron-specific enolase in lung cancer

被引：0

作者：

N. E. Kushlinskii

N. V. Lyubimova

A. O. Lemeshko

A. V. Vasil’ev

M. I. Davydov

机构：

[1] Russian Academy of Medical Sciences,Laboratory of Clinical Biochemistry, Department of Thoracal Oncology, Department of Pathological Anatomy of Human Tumors, Research Institute Clinical Oncology, N. N. Blokhin Oncology Research Center

来源：

Bulletin of Experimental Biology and Medicine | 1997年 / 123卷

关键词：

tumor markers; CYFRA 21-1; neuron-specific enolase; lung cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The diagnostic validity of CYFRA 21-1 and neuron-specific enolase is assessed in patients with lung cancer. Serum contents of CYFRA 21-1 and neuron-specific enolase are increased, respectively, in 74 and 67% of patients with various histological variants of lung cancer. Diagnostic sensitivity of CYFRA was 77.2% in lung cancer other than the small cell variant and 76% in small cell lung cancer. A correlation between the CYFRA content and the tumor size in patients with squamous and other than small cell lung cancer is demonstrated. In patients with spread small cell cancer, serum enolase content tends to increase compared with that in patients with localized small cell cancer. Both CYFRA and enolase are sensitive lung tumor markers in the diagnostics and evaluation of the extent of tumor spread.

引用

页码：85 / 87

页数：2

共 50 条

[31] Compensated Interferometry Measures of CYFRA 21-1 Improve Diagnosis of Lung Cancer [J].

Kammer, Michael N. ;

Kussrow, Amanda K. ;

Webster, Rebekah L. ;

Chen, Heidi ;

Hoeksema, Megan ;

Christenson, Robert ;

Massion, Pierre P. ;

Bornhop, Darryl J. .

ACS COMBINATORIAL SCIENCE, 2019, 21 (06) :465-472

[32] Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer [J].

Schneider, J ;

Velcovsky, HG ;

Morr, H ;

Katz, N ;

Neu, K ;

Eigenbrodt, E .

ANTICANCER RESEARCH, 2000, 20 (6D) :5053-5058

[33] WILMS-TUMOR PRODUCING NEURON-SPECIFIC ENOLASE [J].

TOKI, A ;

TODANI, T ;

WATANABE, Y ;

UEMURA, S ;

SATO, Y ;

MOROTOMI, Y .

PEDIATRIC SURGERY INTERNATIONAL, 1993, 8 (02) :165-167

[34] Improving the screening ability of neuron-specific enolase on small cell lung cancer [J].

Wu, Yixian ;

Tang, Yingdan ;

Huang, Wen ;

Zhu, Chen ;

Ju, Huanyu ;

Wu, Juan ;

Zhang, Qun ;

Zhao, Yang ;

Kong, Hui .

LUNG CANCER, 2025, 199

[35] Significance of serum neuron-specific enolase in transient global amnesia [J].

Lee, Dong Ah ;

Jun, Kyung Ran ;

Kim, Hyung Chan ;

Park, Bong Soo ;

Park, Kang Min .

JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 89 :15-19

[36] Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer [J].

Zhou, Yang ;

Chen, Wen-Zhao ;

Peng, Ai-Fen ;

Tong, Wei-Lai ;

Liu, Jia-Ming ;

Liu, Zhi-Li .

TUMOR BIOLOGY, 2017, 39 (07) :1-5

[37] Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects [J].

Isgro, Maria Antonietta ;

Bottoni, Patrizia ;

Scatena, Roberto .

ADVANCES IN CANCER BIOMARKERS: FROM BIOCHEMISTRY TO CLINIC FOR A CRITICAL REVISION, 2015, 867 :125-143

[38] CYFRA 21-1 as a Tool for Distant Metastasis Detection in Lung Cancer [J].

Cabrera-Alarcon, J. L. ;

Carrillo-Vico, A. ;

Santotoribio, J. D. ;

Leon-Justel, A. ;

Sanchez-Gil, R. ;

Gonzalez-Castro, A. ;

Guerrero, J. M. .

CLINICAL LABORATORY, 2011, 57 (11-12) :1011-1014

[39] CYFRA 21-1: An indicator of survival and therapeutic effect in lung cancer [J].

Takei, Y ;

Minato, K ;

Tsuchiya, S ;

Takise, A ;

Nakano, H ;

Ezawa, K ;

Fueki, N ;

Hoshino, H ;

Naruse, I ;

Nomoto, T ;

Makimoto, T ;

Ishihara, S ;

Saito, R ;

Mori, M .

ONCOLOGY, 1997, 54 (01) :43-47

[40] CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis [J].

Cho, Hye-yon ;

Kyung, Min Sun .

MEDICAL SCIENCE MONITOR, 2019, 25 :1087-1092

← 1 2 3 4 5 →